Viewing Study NCT02775851


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-09 @ 10:34 AM
Study NCT ID: NCT02775851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2016-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
Organization: